(Нет сведений об экземплярах) Шифр: ЕУ12/2012/34/4 Журнал 2012г. т.34 N 4 Theoretical ground for adsorptive therapy of anthracyclines cardiotoxicity. - P.314-322 : il Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: Increased efficiency for resistant tumor model . - P.323-326 : il Wysokinski, D. Zink differentially modulates DNA damage Induced by anthracyclines in normal and cancer cells / D. Wysokinski, J. Blasiak, K. Wozniak. - P.327-331 : табл. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model . - P.332-335 : цв.ил Nanohyperthermia of malignant tumors. II in vivo tumor heating with manganese perovskite nanoparticles . - P.336-339 : граф. Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice . - P.340-347 : граф. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer? . - P.348-353 : табл. Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer : Coference reports. - P.354-357 : табл. Shapochka, D. O. Relationship between NF-KB, ER, PR, HER2/NEU, KI67, P53 expression in human breast cancer / D.O. Shapochka, S.P. Zaletok, M.I. Gnidyuk. - P.358-363 : табл. Chronobiological approaches to antiangiogenic photodynamic therapy of tumors: The first experimental evaluation . - P.364-366 : граф. Sensitivity of human laryngeal squamous cell carcinoma HEP-2 to metrotexate chemotherapy. - P.367-369 : il Hypermethylation of TUSC5 genes in breast cancer tissue. - P.370-372 : цв.ил Senthilkumar, C. S. Lenalidomide-based combined therapy induced alterations in serum proteins of multiple myeloma patient: A follow-up case report and overview of the literature / C.S. Senthilkumar, N. Ganesh. - P.373-376 : табл. Materials of hematology tutorial "Diagnostic work-up of hematological malignancies. Focus on lymphoid malignancies", May 18-19, 2012, Kyiv, Ukraine. - P.377-388 Нет сведений об экземплярах |
Wysokinski, D. Zink differentially modulates DNA damage Induced by anthracyclines in normal and cancer cells [Text] / D. Wysokinski, J. Blasiak, K. Wozniak // Experimental Oncology : An Internanational Scientific Journal. - 2012. - Том34, N4. - P327-331 : табл. - 31 ref. . - ISSN 1812-9269 Рубрики: ЛЕЙКОЗ-ЛИМФОМА ПРЕ-КЛЕТОЧНЫЙ ЛИМФОБЛАСТНЫЙ--PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA ЦИНК--ZINC ДОКСОРУБИЦИН--DOXORUBICIN ИДАРУБИЦИН--IDARUBICIN АНТРАЦИКЛИНЫ--ANTHRACYCLINES ДНК ПОВРЕЖДЕНИЕ--DNA DAMAGE Доп.точки доступа: Blasiak, J.; Wozniak, K. Экз-ры: |
Шифр: ЕУ12/2020/42/2 Журнал 2020г. т.42 N 2 Shvets, Yu. V. Human microbiota and effectiveness of cancer chemotherapy / Yu. V. Shvets, N. Yu. Lukianova, V. F. Chekhun. - P.82-93 Zadvornyi, T. V. Nanog as prognostic factor of prostate cancer course / T. V. Zadvornyi [et al.]. - P.94-100 Другие авторы: Lukianova N. Yu., Borikun T. V., Vitruk Yu. V., Stakhovsky E. O., Chekhun V. F. Lamdan, H. Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin / H. Lamdan [et al.]. - P.101-108 Другие авторы: Garcia-Lazaro R. S., Lorenzo N., Galigiuri L. G., Alonso D. F., Farina H. G. Antonenko, S. V. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells / S. V. Antonenko, G. D. Telegeev. - P.109-114 Onyshchenko, K. V. Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma / K. V. Onyshchenko [et al.]. - P.115-119 Другие авторы: Voitsitskyi T. V., Grygorenko V. M., Saidakova N. O., Pereta L. V., Onyschuk A. P., Skrypkina I. Ya. Stegantseva, M. V. Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model / M. V. Stegantseva [et al.]. - P.120-125 Другие авторы: Shinkevich V. A., Tumar E. M., Meleshko A. N. Andreieva, S. V. Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias / S. V. Andreieva [et al.]. - P.126-129 Другие авторы: Kyselova O. A., Serbin I. M., Alkhimova O. G. Bialik, P. HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer / P. Bialik [et al.]. - P.130-134 Другие авторы: Wysokinski D., Slomka M., Morawiec Z., Strapagiel D., Wozniak K. Pankaj, D. Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study / D. Pankaj, V. Guddattu, M. C. Solomon. - P.135-139 Lyalkin, S. A. Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer / S. A. Lyalkin [et al.]. - P.140-143 Другие авторы: Verevkina N. O., Alekseyenko O. O., Syvak L. A. Perekhrestenko, T. Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy / T. Perekhrestenko [et al.]. - P.144-147 Другие авторы: Melnyk U., Goryainova N., Diagil I. Glavatskyi, O. Ya. Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy / O. Ya. Glavatskyi [et al.]. - P.148-156 Другие авторы: Zemskova O. V., Khmelnytskyi H. V., Kardash K. A., Shuba I. M., Stuley V. A. Kliusov, O. M. Specialized care provided to patients with rectal cancer in Kyiv city / O. M. Kliusov. - P.157-160 Имеются экземпляры в отделах: (свободен) |